Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Apr 6 · below the Ichimoku cloud · RSI 24 (oversold) · MACD above its signal
None of the 29 investors followed here reported a position in ELAB in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a ELAB trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for ELAB.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -40.7 | -66.1 | -16.1 | -58.9 | -28.0 | -31.6 | -23.7 | -43.8 | -31.8 | -16.1 | −99.2% | ||
| 2025 | -25.3 | -27.2 | -46.9 | -50.5 | -8.7 | 3.3 | -3.2 | -22.5 | -6.9 | 12.0 | -10.4 | -72.1 | −97.4% |
| 2024 | -62.2 | 0.9 | -0.3 | 0.9 | -5.8 | -12.1 | -19.5 | -43.0 | -68.8 | -28.9 | -82.6 | 11.7 | −99.4% |
| 2023 | -34.9 | −34.9% |
No analyst coverage for this instrument.
PMGC Holdings Inc., doing business as NorthStrive Holdings, Inc, a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.